Keros heads into 2026 with rinvatercept catalysts in DMD and ALS as investors watch phase II plans, orphan status and early ...
SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare ...
There is no single test to diagnose motor neurone disease. So it is generally only through referral to a neurologist, then ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results